Biodexa Pharmaceuticals Plc
BDRX
$7.57
$0.060.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.53M | 5.21M | 2.09M | 2.24M | 6.39M |
| Total Receivables | 6.79M | 6.40M | 895.10K | 958.30K | 3.12M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 8.04M | 8.61M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.32M | 11.62M | 11.03M | 11.81M | 9.51M |
|
|
|||||
| Total Current Assets | 12.32M | 11.62M | 11.03M | 11.81M | 9.51M |
| Net Property, Plant & Equipment | 256.20K | 241.60K | 405.60K | 434.30K | 551.00K |
| Long-term Investments | -- | -- | 0.00 | 0.00 | 0.00 |
| Goodwill | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Intangibles | 7.73M | 7.29M | 7.07M | 7.57M | 7.59M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 20.31M | 19.15M | 18.50M | 19.81M | 17.65M |
|
|
|||||
| Total Accounts Payable | 1.94M | 1.83M | 885.10K | 947.60K | 2.13M |
| Total Accrued Expenses | -- | -- | 1.59M | 1.71M | -- |
| Short-term Debt | 686.40K | 647.30K | 538.30K | 576.30K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 224.10K | 239.90K | 219.90K |
| Total Finance Division Other Current Liabilities | 772.70K | 728.70K | 3.06M | 3.28M | 2.04M |
| Total Other Current Liabilities | 772.70K | 728.70K | 3.06M | 3.28M | 2.04M |
| Total Current Liabilities | 3.40M | 3.20M | 6.30M | 6.75M | 4.40M |
|
|
|||||
| Total Current Liabilities | 3.40M | 3.20M | 6.30M | 6.75M | 4.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 686.40K | 647.30K | 538.30K | 576.30K | -- |
| Capital Leases | -- | -- | 147.70K | 158.20K | 262.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.25M | 1.17M | 1.64M | 1.75M | 1.96M |
| Total Liabilities | 4.64M | 4.38M | 8.08M | 8.66M | 6.62M |
|
|
|||||
| Common Stock & APIC | 133.98M | 126.35M | 117.00M | 125.26M | 119.89M |
| Retained Earnings | -211.17M | -199.14M | -188.32M | -201.61M | -186.89M |
| Treasury Stock & Other | 92.85M | 87.56M | 81.74M | 87.51M | 78.03M |
| Total Common Equity | 15.67M | 14.78M | 10.42M | 11.15M | 11.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.67M | 14.78M | 10.42M | 11.15M | 11.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.67M | 14.78M | 10.42M | 11.15M | 11.03M |
|
|
|||||